Product Details
Vorinostat (SAHA) for Tablets BP
Product Name
:
Vorinostat (SAHA) for Tablets BP
Brand Name
:
VEROVOR
Available Strength
:
100 mg
Packing
:
60 Tablets
Pack Insert/Leaflet
:
According To Your Needs
These film-coated tablets meet British Pharmacopoeia standards, supporting targeted oncology treatment. Oncologists prescribe Vorinostat for hematologic malignancies where histone deacetylase inhibition offers therapeutic benefit.
Vorinostat (SAHA) BP (100 mg) is a histone deacetylase (HDAC) inhibitor that alters gene expression involved in cancer cell growth, differentiation, and survival. As a result, it can induce cell cycle arrest and programmed cell death in susceptible malignant cells. Because of this targeted mechanism, oncology specialists prescribe it under close supervision as part of a broader treatment plan. Therefore, hospitals and oncology clinics rely on it for eligible patients under specialist care.
Key Features
- Meets BP (British Pharmacopoeia) standards for consistent quality
- Delivers targeted HDAC inhibition for oncology treatment
- Ensures accurate, validated dosing in every batch
- Manufactured under GMP-compliant, high-alert medication handling protocols
- Intended strictly for use under oncologist supervision
- Restricted to hospital, oncology clinic, and specialist institutional supply